Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. (ALLO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ALLO · as of Jun 9, 2026
Key Statistics
Explore Allogene Therapeutics, Inc. Data
allo stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 30 · Buy rate: 63.3%
The ALLO analyst consensus is Buy, based on ratings from 30 Wall Street analysts over the past 3 months. The average 12-month price target is $6.43, representing +247.57% upside from the current price of $1.85.
Competitors & Peers
allo competitorsALLO
ACHV
AVIR
CABA
CRBU
EDITStock Performance
Full HistoryAbout Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. operates as a clinical-stage immuno-oncology firm dedicated to the creation and commercialization of genetically engineered allogeneic T-cell therapies for the treatment of…
what is allogene therapeutics, inc. · allo stock overview · allogene therapeutics, inc. company profile · who is allogene therapeutics, inc. ceo · allo NASDAQ · allogene therapeutics, inc. headquarters · allogene therapeutics, inc. business segments
About Stock Overview & Key Data
Allogene Therapeutics, Inc. (ALLO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 11, 2018. As of the latest trading session, ALLO stock price is $1.85, with a market capitalization of $451.2M. The stock has returned +31.82% over the past 12 months and +35.66% year-to-date.
According to 30 Wall Street analysts, the consensus rating for Allogene Therapeutics, Inc. stock is Buy, with an average 12-month price target of $6.43. In fiscal year 2025, Allogene Therapeutics, Inc. reported revenue of — and net income of -$190.9M. For detailed data — including Allogene Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Allogene Therapeutics, Inc. (ALLO) stock price is $1.85. The stock is traded on NASDAQ under the ticker symbol ALLO. The 52-week range is $0.98 – $4.46.